Possibilities of antihypertensive therapy in correction of cognitive impairment in hypertensive patients
DOI:
https://doi.org/10.12775/JEHS.2020.10.01.017Keywords
hypertension, cognitive impairment, antihypertensive therapyAbstract
Data regarding possibilities of antihypertensive therapy to reduce a risk of the development of new cases of cognitive impairment are contradictory. So, the purpose of the study was to analyze the effect of antihypertensive therapy onto the dynamics of cognitive functions in hypertensive patients. We examined 90 patients with stage 1 and 2 hypertension, 2-3 degrees (middle age of patients was 49,66 ± 8,74 years). Clinical and anamnestic examination, laboratory and instrumental methods of examination were done to all patients. Neuropsychological tests, as GPCOG, MMSE, Schulte tables were used to study cognitive functions. Cognitive impairment were observed in 36 patients (40%). The combination of inhibitors of angiotensin-converting enzymes (іАCE) or angiotensin II receptor blockers (ARB) + calcium channel blocker (CCB) was used as antihypertensive therapy. While using this therapy not only the decrease and normalization of blood pressure but also improvement of cognitive functions were noticed. Particularly, in 61,29% cases patients gained obviously more points in the retesting MMSE(p=0,003) and GPCOG(p=0,01) and almost all patients (96,77%) needed less time to fulfill tasks by Schulte tables (p=0,0001). The total sum of points by MMSE scale increased by 3,66% (p=0,003), the total score by GPCOG scale increased by 22,24% (p=0,01), and in the control execution of Schulte test patients used less time by 14,39 % in comparison with initial results (p=0,0001).
References
Launer LJ. Midlife blood pressure and dementia: the Honolulu-Asia agingstudy / Launer LJ., Ross GW., Petrovitch H. [etal.] //NeurobiolAging. – 2000. – Vol. 21. – P. 49-55.
LeviMarpillat N. Antihypertensive classes, cognitive decline and incidence of dementia:a network meta-analysis / LeviMarpillat N., Macquin-Mavier I., Tropeano AI., Bachoud-Levi AC., Maison P. // J Hypertens. – 2013. – Vol. 31(6). – P. 1073–1082.
Hanon O. Effects of hypertension therapy based on eprosartanon systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study / Hanon O., Berrou JP., Negre-Pages L., Goch JH., Nadhazi Z., Petrella R. [etal.] // J Hypertens. – 2008. – Vol. 26(8). –Р. 1642–1650.
Fogari R. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension / Fogari R., Mugellini A., Zoppi A., Marasi G., Pasotti C., Poletti L., Rinaldi A., Preti P. // European Journal of Clinical Pharmacology. – 2004. – Vol.59. – Р. 863–868
Hajjar I. Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial / Hajjar I., Hart M., Chen Y.L., Mack W., Milberg W., Chui H.,Lipsitz L. // Arch. Intern. Med. – 2012. – Vol. 172(5). – P. 442-444.
McGuinness B. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia / McGuinness B., Todd S., Passmore P., Bullock R. // Cochrane Database of Systematic Reviews. – 2009. – Vol.4, doi.org/10.1002/14651858.CD004034.pub2
Watfa G, Rossignol P, Kearney-Schwartz A, Fay R, Bracard S,Felblinger J, etal. Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints. J Hypertens. 2010, № 28(12), Р. 2485–2493.
Primce M.J., Bird A.S., Blizard R.A. Is the cognitive function of alder patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council’s treatment trial of hypertension in older adults. BMJ 1996, № 312, P. 801–805.
Diz DI, Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension. 2008, № 52(1), Р. 37–43.
Gustafson DR, Melchior L, Eriksson E, Sundh V, Blennow K, Skoog I. The ACE insertion deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset. Neurobiol Aging.2010, № 31(6), Р. 910–916.
Basso N, Paglia N, Stella I, de Cavanagh EM, Ferder L, del Rosario LoresArnaizM, et al. Protective effect of the inhibition of the reninangiotensin system on aging. RegulPept. 2005, № 128(3), Р. 247–252.
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 266
Number of citations: 0
